Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis.

We compared Ro 11-8958, an analog of trimethoprim (TMP) with improved antimicrobial and pharmacokinetic properties, other dihydrofolate reductase (DHFR) inhibitors, sulfamethoxazole (SMX), and dapsone (DAP) in the treatment of Pneumocystis carinii pneumonia in an immunosuppressed rat model. In contr...

Popoln opis

Bibliografske podrobnosti

izdano v:	Antimicrob Agents Chemother
Principais autores:	Walzer, P D, Foy, J, Steele, P, White, M
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1993
Teme:	Research Article
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC187990/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8363372/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.7.1436
Oznake:	Označite Brez oznak, prvi označite!